tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Want to see IKT full AI Analyst Report?

Compare Inhibikase Therapeutics (IKT) vs. Competitors

381 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Inhibikase Therapeutics
$1.83
$271.99M
-3.96
-1.90%
5 Buy
0 Hold
0 Sell
Strong Buy
Atossa Therapeutics
$5.83
$48.22M
-1.18
-53.90%
4 Buy
0 Hold
0 Sell
Strong Buy
Anixa Biosciences
$3.16
$100.58M
-9.85
14.07%
2 Buy
0 Hold
0 Sell
Moderate Buy
Spero Therapeutics
$2.59
$148.20M
1.04
345.22%
Surrozen
$31.56
$336.24M
-0.63
233.29%
5 Buy
0 Hold
0 Sell
Strong Buy
TScan Therapeutics
$1.19
$82.34M
-1.14
-8.70%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IKT
Inhibikase Therapeutics
2.06
0.06
3.00%
ATOS
Atossa Therapeutics
5.60
-6.65
-54.29%
ANIX
Anixa Biosciences
3.00
0.39
14.94%
SPRO
Spero Therapeutics
2.56
1.94
312.90%
SRZN
Surrozen
28.96
20.61
246.83%
TCRX
TScan Therapeutics
1.26
-0.01
-0.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts